Brief: Coherus Biosciences Says Capacity Constraints At Labeling & Packaging Facility To Cause Udenyca Supply Interruption

Coherus Oncology

13/09/2024 23:18

Sept 13 (Reuters) - Coherus BioSciences Inc  CHRS.O :
    * COHERUS BIOSCIENCES: A 3RD-PARTY CMO SAID CAPACITY
CONSTRAINTS
AT FINAL LABELING & PACKAGING FACILITY TO CAUSE TEMPORARY
UDENYCA SUPPLY INTERRUPTION
    * COHERUS BIOSCIENCES INC -  PROJECTS CHANNEL SUPPLY UDENYCA
TO BE
SUBSTANTIALLY DEPLETED BY MID-OCTOBER AS INVENTORIES DRAW DOWN
    * COHERUS BIOSCIENCES: EXPECTS UDENYCA MANUFACTURING TO
RESUME IN
MID-OCTOBER, WITH PRODUCT AVAILABILITY TO BEGIN TO RESUME BY
EARLY NOVEMBER
    * COHERUS BIOSCIENCES - TO WORK WITH WHOLESALERS &
PRESCRIBERS TO
MINIMIZE ANY DISRUPTION FROM TEMPORARY SUPPLY INTERRUPTION
    * COHERUS BIOSCIENCES INC - COMPANY PROJECTS THAT THESE
ACTIONS
WILL COLLECTIVELY REDUCE PRODUCTION COST OF UDENYCA BY
APPROXIMATELY ONE-THIRD FROM CURRENT LEVELS
    * COHERUS BIOSCIENCES - ENGAGED ADDITIONAL FINAL PACKAGING &
LABELING CMO, TO MANUFACTURE UDENYCA BY 2024 END
    * COHERUS BIOSCIENCES- COMMERCIAL SUPPLY OF UDENYCA FROM NEW
CMO
TO START IN Q1 2025

Source text for Eikon:  ID:n0001558370-24-012783 
Further company coverage:  CHRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))